|
Blundell, T.L., Burke, D. F., Chirgadze, D., Dhanaraj, V., Hyvönen, M., Innis, C. A., Parisini, E., Pellegrini, L., Sayed, M. and Sibanda, B. L. (2000). Protein-protein interactions in receptor activation and intracellular signaling. Biol. Chem. 381, 955-959.
Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A. and Comoglio, P. M. (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119, 629-641.
Date, K., Matsumoto, K., Shimura, H., Tanaka, M. and Nakamura, T. (1997). HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett. 420, 1-6.
Gohda, E., Tsubouchi, H., Nakayama, H., Hirono, S., Takahashi, K., Koura, M., Hashimoto, S. and Daikuhara, Y. (1986). Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp. Cell Res. 166, 139-150.
Gherardi, E., Youles, M. E., Miguel, R. N., Blundell, T. L., Iamele, L., Gough, J., Bandyopadhyay, A., Hartmann, G. and Butler, P. J. (2003). Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor / scatter factor. Proc. Nat. Acad. Sci. 100, 12039-12044.
Gmyrek, G. A., Walburg, M., Webb, C. P., Yu, H. M., You, X., Vaughan, E. D. Woude, G. F. V. and Knudsen, B. S. (2001). Normal and malignant protease epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am. J. Pathol. 159, 579-590.
Jiang, W. G., Hiscox, S. E., Parr, C., Martin, T. A., Marsumoto, K., Nakamura, T. and Mansel, R. E. (1999). Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in Vitro angiogenesis of human vascular endothelial cells. Clin. Cancer Res. 5, 3695-3703.
Jiang, Y., Xu, W., Lu, J., He, F. and Yang, X. (2001). Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Biochem. Biophy. Res. Comm. 286, 1123-1130.
Kermorgant, S., Aparicio, T., Dessirier, V., J.M.Lewin, M. and Lehy, T. (2001). Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis. 22, 1036-1042.
Kirchhofer, D., Yao, X., Peek, M., Eigenbrot, C., Lipari, M. T., Billeci, K. L., Maun, H. R., Moran, P., Santell, L., Wiesmann, C. and Lazarus, L. A. (2004). Structural and functional basis of the serine protease-like hepatocyte growth factor β-chain in Met binding and signaling. J. Biol. Chem. 279, 39915-39924.
Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M. and Nakamura, T. (2000). HGF/NK4, a four-kringle antagonist of heaptocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer res. 60, 6737-6743.
Lokker N. A. and Godowski, P. J. (1993). Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/NK1. J. Biol. Chem. 268, 17145-17150.
Lokker, N. A., Mark, M. R., Luis, E. A., Bennett, G. L., Robbins, K. A., Baker, J. B. Godowski, P. J. (1992). Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J. 11, 2503-2510.
Lokker N. A., Presta, L. G. and Godowski, P. J. (1994). Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor. Protein Eng. 7, 895-903.
Ma, H., Calderon, T. M., Kessel, T., Ashton, A. W. and Berman, J. W. (2003). Mechanisms of hepatocyte growth factor-mediated vascular smooth muscle cell migration. Circ. Res. 93, 1066-1073.
Martin, T. A., Parr, C., Davies, G., Watkins, G., Lane, J., Matsumoto, K., Nakamura, T., Mansel, R. E. and Jiang, W. G. (2003). Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. Carcinogenesis. 24, 1317-1323.
Matsumoto, K., Takehara, T., Inoue, H., Hagiya, M., Shimizu, S. and Nakamura, T. (1991). Deletion of kringle domains or the N-terminal hairpin structure in hepatocyte growth factor results in marked decreases in related biological activities. Biochem. Biophy. Res. Commun. 181, 691-699.
Merry, C. L. R., Bullock, S. L., Swan, D. C., Backen, M. L., Beddingtonm R. S. P., Wilson, V. A. and Gallagher, J. T. (2001). The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. J. Biol. Chem. 276, 35429-35434.
Miyazawa, K., Shimomura, T., Kitamura, A., Kondo, J., Morimoto, Y. and Kitamura, N. (1993). Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J. Biol. Chem. 268, 10024-10028.
Mizuno, K., Inoue, H., Hagiya, M., Shimizu, S., Nose, T., Shimohigashi, Y. and Nakamura, T. (1994). Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J. Biol. Chem. 269, 1131-1136.
Naka, D., Ishii, T., Yoshiyama, Y., Miyazawa, K., Hara, H., Hishida, T. and Kitamura, N.(1989). Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J. Biol. Chem. 267, 20114-20119.
Nakamura, T., Nawa, K., Ichihara, A., Kaise, N. and Nishino, T. (1987). Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 224, 311-316.
Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K. and Shimizu, S. (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature. 342, 440-443.
Nakamura, T., Teramoto, H. and Ichihara, A. (1986). Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. 83, 6489-6493.
Nicola, N. A. (1994). Guidebook to cytokines and their receptors. Oxford University Press.
Parr, C., Watkins, G., Mansel, R. E. and Jiang, W. G. (2004). The hepatocyte growth factor regulatory factors in human breast cancer. Clin. Cancer Res. 10, 202-211.
Rahimi, N., Etchells, S. and Elliott, B. (1996). Hepatocyte growth factor (HGF) is a copper-binding protein: a facile probe for purification of HGF by immobilized Cu(Ⅱ)-affinity chromatography. Protein Expr. Purif. 7, 329-333.
Rainon, T. M., England, P., Ding, S., Demerens, C. and Tobelem, G. (2003). The N-termial domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor. J. Biol. Chem. 278, 37400-37408.
Rosen, E. M., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L. and Polverimi, P. (1993). Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo. Symp. Soc. Exp. Biol. 47, 227-234.
Russell, W. E., McGowan, J. A. and Bucher, N. L. (1984). Partial characterization of a hepatocyte growth factor from rat platelets. J. Cell Physiol. 119, 183-192.
Saccone, S., Narsimhan, R. P., Gaudino, G., Dalpra, L., Comoglio, P. M. and Della Valle, G. (1992). Regional mapping of the human hepatocyte growth factor (HGF)-scatter factor gene to chromosome 7q21.1. Genomics. 13, 912-914.
Schiering, N., Knapp, S., Marconi, M., Flocco, M. M., Cui, J., Perego, R., Rusconi, L. and Cristiani, C. (2003). Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a. Proc. Nat. Acad. Sci. 100, 12654-12659.
Stamos, J., Lazarus, R. A., Yao, X., Kirchhofer, D. and Wiesmann. (2004). Crystal structure of the HGF b-chain in complex with the Sema domain of the Met receptor. EMBO J. 23, 2325-2335.
Soker, S., Gollamudi-Payne, S., Fidder, H. and Charmahelli, H. (1997). Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. J. Biol. Chem. 272, 31582-31588.
Tomikawa, M., Hashizume, M., Highashi, H.,Ohta, M. and Sugimachi, K. (1996). The role of the spleen, platelets, and plasma hepatocyte growth factor activity on hepatic regeneration in rats. J. Am. Coll. Surg. 182, 12-16.
Ultsch, M., Lokker N. A., Godowski, P. J. and Vos, A. M. (1998). Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 Å resolution. Structure. 6, 1383-1393.
Weidner, K. M., Arakaki, N., Hartmann, G., Vandekerckhove, J., Weingart, S., Rieder, H., Fonatsch, C., Tsubouchi, H., Hishida, T., Daikuharat, Y. and Birchmeier, W. (1991). Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc. Nat. Acad. Sci. 88, 7001-7005.
Weidner, K. M., Behrens, J., Vandekerckhove, J. and Birchmeier, W. (1990). Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell. Biol. 111, 2097-2108.
Wright, T. G., Tsai, J., Jia, Z. and Elliott, B. E. (2004). Inhibition by copper(Ⅱ) binding of hepatocyte growth factor (HGF) interaction with its receptor Met and blockade of HGF/Met function. J. Biol. Chem. 279, 32499-32506.
Yamagata, T., Muroya, K., Mukasa, T., Igarashi, H., Momoi, M., Tsukahara, T., Arahata, K., Kumagai, H and Momoi, T. (1995). Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors. Biochem. Biophys. Res. Commun. 5, 231-237.
Zioncheck, T. F., Richardson, L., Liu, J., Chang, L., King, K. L., Bennett, G. L., Fügedi, P., Chamow, S. M., Schwall, R. H. and Stack R. J. (1995). Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J. Biol. Chem. 270, 16871-16878.
|